AARTI KAPUR: Open Payments
NPI 1922216902 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 15 payments from 10 companies in 2025. Trend: 2023 $1,291 · 2024 $705 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $142 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Braeburn Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $100 |
| ABBVIE INC. | 4 | $69 |
| Lundbeck LLC | 2 | $36 |
| TMS NeuroHealth Centers Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, SPRAVATO, BRIXADI, CAPLYTA, VRAYLAR, REXULTI, TMS NeuroHealth Centers Inc., TRINTELLIX.
Industry payments across NC — which companies pay providers there.
